We established conditions for inducing antigen-specific tolerance in T h 2 lymphocytes by means of oral tolerance. Mice were continuously exposed to ovalbumin in their drinking water for a minimal period of 20 days and then immunized against antigen in either complete Freund's adjuvant or AI(OH) 3 . This feeding regimen tolerized both T h 2 and T h 1 responses as shown by diminished proliferation, cytokine secretion (IL-4, IL-2 and IFN-Y) and specific cytokine mRNA expression (IL-4, IL-2 and IFN-Y) in vitro, as well as by absence of specific antibody production (lgG1, lgG2a, lgG2b and IgE) in vivo. Conditions for generating T h 2 lymphocyte tolerance were different from those required to generate tolerance in T h 1 lymphocytes: these included extended, continuous exposure to high dosages of antigen, rather than a single or intermittent feeding regimen which was sufficient to induce tolerance in T h 1 lymphocytes. These findings suggest that continuous oral exposure to a tolerogen may be a biologically relevant strategy to tolerize both T h 1-and Independent responses, and extend the potential clinical use of oral tolerance to ailments mediated by T h 2 lymphocytes.
Introduction
The gut associated lymphoid tissue is capable of generating both immunological tolerance (oral tolerance) and immune response (oral immunization) against antigens administered by the oral route. Conditions that distinguish between tolerance or immune response have not been clearly defined and might include sight of antigen entry (Peyer's patch or lamina propria) or the physical state of antigen (soluble or paniculate) (1, 2) . Since both oral tolerance and oral immunization are relevant for treatment of human diseases (1) (2) (3) , definition of these conditions is of major importance: immune responses should be avoided if tolerance is the objective and vice versa. Antigen feeding as a means to generate peripheral tolerance in CD4 + cells has been thus far successful in tolerization of T h 1 type responses, while those of T h 2 lymphocytes appeared to be intact (4) (5) (6) . Similar difficulties in generating tolerance of T h 2 lymphocytes in vitro or of T h 2-mediated antibody production in vivo have been encountered in other experimental systems in which tolerance was induced by i.v. or i.p. administration of soluble antigens (7) (8) (9) (10) (11) (12) . Thus, after tolerization by the oral or parenteral route, IL-2 and IFNy were not produced in cultures and a diminished lgG2a antibody response was observed in vivo (tolerance of T h 1 responses). In contrast, IL-4 production in vitro and lgG1 responses in vivo were intact (intact T h 2 responses). The conclusion drawn from these studies was that T h 2 lymphocytes were resistant to tolerance induction in the periphery.
In contrast to these findings, earlier studies showed that feeding mice with large dosages of antigen led to tolerization of specific IgE-dependent cutaneous anaphylaxis. More recently, significant, though not complete, tolerization of T h 2 responses was achieved by the i.v. injection of deaggregated human y-globulin. These studies indicated that oral, or peripheral, tolerization of T h 2 lymphocytes might require different conditions than those required to tolerize T h 1 lymphocytes and, thus, the present study was undertaken to determine conditions to orally tolerize T h 2 lymphocytes. Since T h 2 lymphocytes appeared to be more resistant to tolerance induction, we postulated that oral tolerization of T h 2 lymphocytes might require either larger antigen dosages or constant exposure to antigen in a manner that would prevent its rapid clearance from the blood. To directly evaluate these possibilities we modified a feeding regimen previously shown to exclusively tolerize T h 1 lymphocytes and that delivered antibody-recognizable antigen into the blood, and demonstrate herein that both T h 1-and T h 2-dependent immune responses can be orally tolerized in an antigen-specific manner.
Methods

Experimental animals
Female BALB/C mice, 6-8 weeks of age, were used in all experiments. The mice were bred in our animal breeding unit (Rehovot) and were maintained in a temperature-and lightcontrolled environment with free access to feed and water. During experiments, mice continuously fed with ovalbumin (OVA, see below) had free access to OVA solution in water, instead of water alone. Each experimental group contained no less than five mice.
Antigens, feedings and immunizations
Antigens used were OVA (Sigma, St Louis, MO) and purified protein derivative of Mycobactrium tuberculosis (PPD; Statens, Denmark). Oral tolerance to OVA was induced by continuous oral exposure to a sterile solution of OVA in drinking water (1 mg/ml, unless otherwise stated) for a period of 20 days (unless otherwise stated). To reduce the effects of contamination by oral flora, the sterile OVA-water solution was replaced three times each day. Individually caged mice consumed 4 ± 0.25 ml solution/day (or mg 4 ± 0.25 OVA) and average consumption of grouped mice (five per cage) was 4.2 ± 0.35 ml solution/day; these values were similar to those previously published. In several experiments, mice were fed 10 intermittent boluses of OVA in water (8 mg OVA/feeding every second day) over the period of 20 days. Mice were immunized against OVA by injecting 20 \xg OVA/mouse, either emulsified 1:1 in complete Freund's adjuvant (CFA) or absorbed by 1 mg AI(OH) 3 . Injections (100 (xl/mouse) were administered i.p.
Assay for anti-OVA antibodies
Presence of lgG1, lgG2a, lgG2b and IgE serum antibodies specific for OVA was tested by ELISA. Sera tested for presence of anti-OVA antibodies were placed on ELISA plates (Nunc, Denmark), previously coated with OVA (or BSA as negative control), followed by biotinylated rat anti-mouse lgG1, lgG2a, lgG2b or IgE detecting mAb (PharMingen, San Diego, CA) and finally by peroxidase-Streptavidin (Kirkegaard & Perry, Gaithersburg, MD). Bound antibodies were detected by TMB (Kirkegaard & Perry) and specific binding was determined by subtracting background binding to BSA. Standard curves were determined for each isotype in each assay by using unlabeled purified standards (all from PharMingen). Antibody concentrations are averages ± SEM/ml serum from no less than five individual mice and are expressed as mg/ml for lgG1, lgG2a, lgG2b and ng/ml for IgE.
Cell cultures
Spleen (erythrocyte depleted) cell cultures were used for proliferation, cytokine secretion and cytokine gene expression assays. Cultures contained cells from individual mice and each experiment was performed with groups containing no less than five mice. The proliferation of T lymphocytes in response to OVA and PPD was assayed as described. Proliferation was measured by MTT oxidation (19) and results are averaged averages of quadruplicate cultures from individual mice expressed in absorbance units (at 570-630 nm) ± SEM. For cytokine secretion, 1X10 7 cells/well (in 1 ml) were cultured in 24-well plates (Nunc) with or without OVA (1 mg/ml). Cytokine secretion was determined temporally in supernatants collected from these cultures and was ascertained to be optimal after 9 h culture for IL-4 detection, 20 h for IL-2 detection and 48 h for IFN-y detection. Collected supernatants were frozen and stored at -70°C till assayed (see below). For the assay of cytokine gene expression, 5x10 7 spleen cells/ml were cultured with or without OVA (1 mg/ml) for 6 h. After incubation, cells were collected and total RNA was isolated for RT-PCR (see below). DMEM was used for all cultures, and was supplemented with 100 U/ml penicillin, 100 ng/ml streptomycin, 2 mM L-glutamine, 1 mM sodium pyruvate, 0.1 mM non-essential amino acids (all supplied by Biological Industries, Beit Haemek, Israel), 5X1O~5 M 2-mercaptoethanol and 0.5% syngeneic serum.
Cytokine assays
Levels of IL-4, IL-2 and IFN-y in supernatants were determined by capture ELISA as described. Briefly, supernatants were added to microtiter plates, previously coated with rat anti-mouse IL-4, IL-2 or IFN-ymAb (capture antibodies, PharMingen) and blocked with BSA-diluent/blocking solution (Kirkegaard & Perry). Biotinylated rat anti-mouse IL-4, IL-2 or IFN-y mAb (detecting antibodies, PharMingen) were added, and followed by peroxidase-labeled streptavidin. Bound cytokine was detected by the addition of ABTS (Kirkegaard & Perry). Cytokine levels were calculated from a log-log plot of absorbance versus concentration of recombinant cytokines (PharMingen) and results are expressed in pg/ml (for IL-4 and IL-2) or ng/ml (for IFN-y). Threshold sensitivities of ELISA assays were 5 pg/ml, 10 pg/ml and 2.5 ng/ml for IL-4, IL-2 and IFN-y respectively. IL-2 and IL-4 levels were also determined by bioassay using the CTLL-2 (IL-2-dependent) and CT.4S (IL-4-dependent; kindly provided by Dr W. E. Paul, NIH, Bethesda MD) cell lines as described (6) .
Analysis of cytokine mRNA levels
Total RNA was isolated from cultured spleen cells using a TRI reagent (Molecular Research Center, Cincinnati, OH), according to a protocol provided by the manufacturer. mRNA was than reverse transcribed into cDNA, and the expression levels of IL-4, IL-2, IFN-y and p-actin messages were determined by a quantitative PCR using cytokine specific primers, p-actin, IL-2 and IFN-y primer sequences were those from Stratagene (La Jolla, CA). IL-4 sequences were as follows: IL-4 sense: 5'-CAGCTAGTTGTCATCCTGCTC-3' (76-97) and IL-4 antisense: 5'-CAGGAAGTCTTTCAGTGA-TGTGAA-3' (445-421). All primers used spanned genomic introns such that any contaminating genomic DNA was detected by a higher molecular weight band. Quantitative PCR conditions were first established for all sets of primers using either cDNA from concanavalin A-activated spleen cells
Tolerance of 1^2 lymphocytes induced by feeding 719 or plasmid DNA. These were subjected to eight 2-fold serial dilutions and amplified for 25 cycles at 95°C for 25 s, 60°C for 60 s and 72°C for 60 s in a 9600 Geneamp PCR System (Perkin-Elmer Cetus, Branehburg, NJ). [ 32 P]dCTP was added directly into the PCR reaction as described (21) and the products were resolved on 5.5% acrylamide gel. mRNA was quantitated using a p-scope (Intelligentics, Mountain View, CA). Tested cDNA samples were amplified undiluted and with two additional two-fold dilutions with cytokine specific primers, and at 1/100, 1/200 and 1/400 serial dilutions with p-actin primer sequences. The ratio of cytokine mRNA expression relative to P-actin was obtained for each dilution and expressed as the mean ratio ± SE.
Statistical analysis
The statistical significance of differences between experimental groups was determined using unpaired two-tailed Student's f-test, with differences considered significant at P<0.05.
Results
Continuous exposure of mice to OVA induces specific T lymphocyte unresponsiveness in vitro
To determine if tolerance could be induced in both T^1 and T h 2 lymphocyte subsets we exposed mice to OVA in their drinking water. Our rational was to achieve conditions in which the experimental antigen was available to mice on a constant basis, rather than a pulse period characterized by a single dose feeding regimen (4). Exposure was continued for 20 days and then mice were immunized by OVA-CFA. Control mice were primed by OVA-CFA or CFA alone. Spleen cell cultures were prepared 10 days after immunization and T lymphocyte proliferation in response to OVA (Fig. 1A) or PPD ( Fig. 1B) was determined. T lymphocytes did not proliferate in response to OVA but exhibited a dose dependent response to PPD which was similar to that of the OVA-primed, nontolerant control group ( Fig. 1 ; P< 0.05 for all antigen doses, representative of six experiments). Identical observations were made with lymph node (popliteal and mesenteric) cell cultures, with other protein antigens (human serum albumin and hen egg lysozyme) and with AI(0H) 3 as adjuvant (data not shown). Thus, continuous oral exposure to external antigens in solution is not an immunogenic stimulus, but induces antigenspecific T lymphocyte unresponsiveness as determined by absence of T lymphocyte proliferation.
Absence of T h 1 and T^ cytokine secretion in cultures derived from mice continuously exposed to OVA in drinking water
Absence of proliferation is only partially indicative of tolerance, since activated non-dividing cells may produce cytokines (22, 23) . Thus, to further establish an in vitro state of tolerance in T lymphocytes derived from mice continuously exposed to OVA in their drinking water, in vitro cytokine secretion was determined. Mice, continuously fed or non-fed controls, were immunized by OVA-CFA or OVA-AI(OH) 3 ; two additional nonfed groups were primed by either CFA or AI(OH)3 alone. Spleen cell cultures were prepared 10 days after immunization, incubated with or without OVA, and supernatants were collected to determine secretion of IL-4, IL-2 and IFN-y (Table  1 , representative of five experiments). Mice continuously exposed to OVA did not secrete IL-4, IL-2 or IFN-y in response to OVA (not at the designated time points and not at any other time point during a 48 h culture period), suggesting that both T h 2 (IL-4 secretors) and T h 1 (IL-2 and IFN-y secretors) OVAspecific lymphocytes were tolerant. This conclusion is supported by the following observations, (i) The three cytokines were secreted in response to OVA in control cultures derived from OVA-CFA and OVA-AI(0H) 3 primed mice, but not in those derived from mice primed by CFA or AI(0H) 3 alone, thus indicating OVA specific activation of both T h 1 and T h 2 lymphocytes in two adjuvant systems (P< 0.05).
(ii) Tolerance was OVA specific as evidenced by the capacity of cells from OVA-CFA exposed mice to secrete cytokines in response to PPD (P < 0.05). The possible presence of IL-4 and IL-2, undetected by ELISA, was further evaluated by bioassays using CT.4S and CTLL-2 cells respectively; IL-2 and IL-4 were not detected in cultures derived from mice continuously exposed to OVA, human serum albumin or hen egg lysozyme, and identical observations were obtained with lymph node cell cultures (data not shown). Hence, continuous oral exposure to antigen in solution induces specific tolerance of T h 2 and T h 1 lymphocytes as determined by in vitro proliferation and cytokine secretion.
Mice continuously exposed to OVA in drinking water do not express T h 1 and T^ cytokine genes
To further evaluate the level of tolerance induced by continuously exposing mice to OVA, we measured cytokine gene expression in response to OVA. Mice, continuously fed or a Mice were continuously exposed to OVA in drinking water tor 20 days (1 mg/ml OVA in water), and then immunized i.p. b Erythrocyte-depleted spleen cells (ixiO 7 /ml) from individual mice were cultured 10 days after immunizations with or without OVA or PPD (1 mg/ml). Cytokine secretion was determined by ELISA. Cytokine levels were calculated from a log-log plot of absorbance versus concentration of recombinant cytokines. Results are averaged averages of quadruplicate cultures from individuals mice ± SEM (n * 5). Values in bold lettering indicate significant cytokine secretion above threshold levels (see Methods) {P < 0.05). b Erythrocyte-depleted spleen cells (5xi0 7 /ml) from individual mice were cultured 10 days after immunizations with or without OVA (1 mg/ ml) for 6 (IL-2 and IL-4) or 12 (IFN-y) h. Cells were collected and total RNA was isolated. mRNA was reverse transcribed into cDNA and the expression levels of IL-4, IL-2, IFN-y and (3-actin messages were determined by quantitative PCR using cytokine specific primers, as described in Methods. Visualized bands were quantitated using a p-scope and cytokine mRNA expression values are relative to those of p-actin mRNA used as an internal control ± SEM (n s= 5). In addition, mRNA expression is presented as the ratio between mRNA expressed in response to OVA and that expressed in response to medium alone. Values in bold lettering indicate significant mRNA expression above levels expressed in response to medium alone (P < 0.05).
non-fed controls, were immunized by OVA-CFA; an additional non-fed group was primed by CFA alone. Spleen cell cultures were prepared 10 days after immunization, incubated with or without OVA, and cells were collected to determine IL-4, IL-2 and IFN-y mRNA expression by quantitative RT-PCR (Table  2 , representative of three experiments). The data show that IL-4, IL-2 and IFN-y mRNA were not expressed in response to OVA by cells derived from mice continuously fed with OVA. In contrast, IL-4, IL-2 and IFN-y mRNAs were specifically elevated in control cultures (P < 0.05). Hence, the state of tolerance in 1^2 and T h 1 lymphocyte subsets was confirmed by absence of cytokine gene expression following a specific antigen stimulus.
Mice continuously exposed to OVA do not secrete 7" h 2-and T h 1-dependent antibodies in vivo
The previous observations indicated that continuous feeding of OVA induced a state of tolerance in T h 2 and T h 1 lymphocyte subsets, as determined by in vitro analysis. To confirm that a similar state was present in vivo we studied profiles of antibodies produced in response to OVA stimulation in tolerant mice. Antibody isotype profiles serve as relative indicators of murine T h subset activity in vivo: lgG1 and IgE production is regulated by IL-4 and represent a T h 2-mediated response, whereas lgG2a and lgG2b production is regulated by IFN-y and represent a T h 1-mediated response (24, 25) . Mice were continuously fed with OVA for 20 days and then primed by OVA-CFA. Control mice were primed by OVA-CFA or CFA alone. Serum samples were collected temporally after immunization (15-60 days) and analyzed for OVA-specific lgG1, IgE, lgG2a and lgG2b secretion (Fig. 2 , representative of five experiments). Mice fed continuously with OVA produced very low, if any, detectable antibody response to OVA; thus anti-OVA lgG1 and IgE, as well as lgG2a and lgG2b, levels were completely diminished. In contrast, control mice primed by OVA-CFA developed significant responses that consisted of all antibody subclasses, indicating that CFA was capable of supporting both T h 2-and T h 1-mediated responses in vivo [AI([OH) 3 promoted selective T h 2-mediated antibody production and could not be used to confirm T h 1 tolerance]. Antibody production was intact in tolerant mice as evidenced by presence of all four subclasses in response to PPD; levels were similar to those of control OVA-CFA immunized mice, and similar results were obtained 20, 30, 45 and 60 days after immunization (data not shown). Taken together the results suggest that both T h 2 and T h 1 responses are susceptible to tolerance induction by continuous oral exposure to antigen. . Serum samples were collected temporally after immunization and individually assayed for IgG 1, IgE, lgG2a and lgG2b by ELISA as described in Methods. Antibody levels are averages ± SEM/ml serum from individual mice (for all isotypes n s= 5).
Tolerance of T^ lymphocytes induced by feeding
Characterization of the tolerogenic signal required for tolerization of T h 2 lymphocytes
Since selective tolerization of T h 1 lymphocytes was accomplished by means of a different feeding regimen (by a single or intermittent feeding regimen; 4), it was of interest to determine comparative requirements for inducing T h 2 lymphocyte tolerance. Three parameters were studied: (i) the rigidity of the feeding regimen, i.e. the necessity for continuous exposure compared with an intermittent feeding regimen, (ii) the minimal antigen dosage required for effective tolerization of T h 2 lymphocytes and (iii) the minimal period required for effective tolerization of T h 2 lymphocytes. The importance of the feeding regimen for tolerization of T h 2 lymphocytes was studied by comparing the degree of tolerance generated by continuous exposure to OVA in drinking water for 20 days to that generated by an intermittent feeding regimen in which mice received the same average dose of OVA (80 mg). Mice were then immunized by OVA-CFA and responses of both groups to OVA were compared 15 days after immunization (Table 3 , representative of four experiments). T^I and T h 2 tolerance resulted from the continuous feeding regimen (both in vitro cytokine production and in vivo antibody secretion), whereas the intermittent feeding regimen caused selective T h 1 tolerance while T h 2 responses (cytokine and antibody) were unchanged, apart from a minor reduction in IL-4 secretion (P > 0.05). Hence, the condition of exposure to antigen was important for generation of T h 2 tolerance.
The minimal antigen dosage required for effective tolerization of T h 2 lymphocytes was determined by continuously exposing mice to different concentrations of OVA in drinking water (0-1 mg/ml) for 20 days. OVA-specific cytokine production in vitro and anti-OVA lgG1 and lgG2a production were assayed 15 days after immunizing mice with OVA-CFA (Fig.  3 , representative of four experiments). Results show that tolerization of cytokine secretion in vitro and antibody responses in vivo required continuous exposure to 1 mg/ml OVA (P < 0.05). A dosage of 0.01 mg/ml had no effect on T lymphocyte functions (P > 0.05), and 0.1 mg/ml had only marginal effects on the measured functions (P = 0.05). Hence, oral tolerization of T h 1-and T h 2-controlled responses (cytokine and antibody production) required relatively high dosages of antigen.
The minimal period required for effective tolerization of T h 2 lymphocytes was determined by evaluating the temporal degree of tolerance generated in vivo by continuously exposing mice to OVA (1 mg/ml). Mice were immunized temporally after feeding was initiated, and serum samples were collected, in each case, 15 days after immunization, and then assayed by ELISA for lgG1 and lgG2a (Fig. 4 , representative of five experiments). As shown, T h 1-mediated responses were most sensitive to tolerance induction: a 1 day period of continuous exposure to OVA was sufficient to dramatically reduce specific lgG2a production, and which essentially ceased after 5 days of exposure. In comparison, T h 2-controlled responses were highly resistant to tolerance induction and became so only a Mice were either continuously exposed to OVA (1 mg/ml) or received daily boluses containing 4 mg/ml for 20 days. b Details of cytokine measurement are as in Table 1 ; concentrations are pg/ml for IL-2 and IL-4, and ng/ml for IFN-y. OVA specific responses are averaged averages of quadruplicate cultures from individual mice ± SEM (r> s= 5) and values in bold lettering indicate significant cytokine secretion above background threshold levels (see Table 1 ) (P < 0.05).
c Serum lgG2a (mg/ml) and IgE (ng/ml) levels were measured 15 days after immunization by isotype specific ELISA, and are averages of individual mice ± SEM/ml serum (n s* 5). Values in bold indicate significant antibody secretion as compared to levels in naive serum (P < 0.05). days of exposure. To summarize, oral tolerization of T h 1 lymphocytes required relatively large dosages of antigen, and was achieved after a brief and intermittent exposure period to antigen. On the other hand, oral tolerization of T h 2 lymphocytes had the same requirements for antigen, but was achieved only after extended and continuous exposure periods.
Discussion
The administration of antigen via the oral route can lead to either tolerance or immunity (1) (2) (3) . In cases were tolerization is the prime objective, feeding regimens and antigen structure appear to be of major importance to insure tolerance and to avoid responsiveness (1, 2) . The objective of the present study was to determine conditions for tolerizing T h 2 lymphocytes following oral administration of antigen. We show here that tolerization of T h 2 lymphocytes, as well as that of T h 1 lymphocytes, was successfully achieved by continuous oral exposure of conventional mice to OVA (and other proteins; data not shown) in water. Tolerance of lymphocyte responses was demonstrated at three levels: in vivo antibody secretion, in vitro proliferation and cytokine secretion, and in vitro cytokine gene expression. These results confirm and extend previous studies which demonstrated tolerization of IgE dependent cutaneous anaphylaxis after antigen feeding (13, 14) and partial tolerization of T h 2 responses after i.v. administration of deaggregated human 7-globulin (15).
Oral tolerance was induced following continuous exposure to OVA in drinking water for 20 days, and was evaluated after immunization of mice by OVA in adjuvant. Tolerance of T h 1 and T h 2 lymphocytes was assessed by absence of proliferation and of IL-4, IL-2 and IFN-y secretion or gene expression in vitro. These observations excluded a state of 'partial activation' in which cells are unable to divide but continued to produce cytokines (26, 27) . Absence of IL-4 secretion and expression in vitro was demonstrated by ELISA, CT.4S proliferation and RT-PCR; together these all indicate tolerization of T h 2 lymphocytes. Similar assays demonstrated T h 1 tolerance too. Support in vivo for these in vitro observations was demonstrated by absence of OVA-specific lgG1 and IgE (isotypes controlled by IL-4), as well as lgG2a and lgG2b (isotypes controlled by IFN-Y). Since IgE is considered to be exclusively T h 2-dependent (24, 25) , its absence confirmed that T h 2-mediated responses were tolerized. Thus, tolerant T h 2 and T h 1 lymphocytes did not secrete IL-4 and IFN-y, and thus, did not provide cytokine signals necessary for isotype switching in B lymphocytes (28) . The possible involvement of B lymphocyte tolerance is discussed below.
The induction of T h 2 tolerance required an extended period of continuous exposure to high dosages of antigen. These conditions were significantly different from those rendering T h 1 lymphocytes tolerant: T h 1 tolerance was achieved by a single or intermittent feeding regimen, did not require extended exposure periods to antigen, but was dependent upon continuous tolerogenic exposures to antigen (4, 6, 16) . Thus, in spite of the fact that similar dosages of antigen were required for induction of tolerance in these T lymphocyte subsets, the distinctive time and exposure patterns indicate different sensitivities to tolerance induction (12) . An interesting point raised by these studies relates to the feeding strategy Tolerance of T h 2 lymphocytes induced by feeding 723 that induced tolerance in OVA-specific T h 2 lymphocytes. Administration of OVA by an intermittent feeding regimen for 20 days did not lead to T h 2 tolerance, while the identical antigen dosage administered ad ibitum in drinking water did. A possible explanation for this observation is based on the role of intestinally absorbed antigen (or its fragments) in the induction of peripheral tolerance (6, (29) (30) (31) and the physiology of renal clearance of proteins (or fragments) from the circulation (15, 32) . An intermittent exposure (every 2 days) to OVA was not sufficient to induce T h 2 lymphocyte tolerance, which are more resistant to tolerance induction than T h 1 lymphocytes (12), because OVA (or fragments) was rapidly being cleared from the circulation by glomerular filtration (32) . On the other hand, an ad libitum feeding regimen provided OVA (or fragments) continuously, and when fed at an adequate dosage, provided the adequate signal forT h 2 tolerance induction. Thus, intra-circulatory OVA was replenished by drinking and possibly persisted for longer periods in body fluids to allow tolerance of all T lymphocyte populations (15) .
Two additional issues are raised by this study: (i) does continuous exposure to antigen induce B lymphocyte tolerance and (ii) what is the mechanism for T h 2 tolerance? Since OVA-specific antibodies were absent in serum of mice continuously exposed to OVA, one could propose that tolerance resulted from both T and B lymphocyte inactivation. Most studies of oral tolerance have indicated T lymphocyte tolerance and intact B lymphocyte responsiveness (33) (34) (35) (36) ; however, these studies were not programmed to achieve T^2 tolerance. On the other hand, studies with transgenic mice have distinctly shown induction of peripheral B lymphocyte tolerance (37) (38) (39) (40) . Thus, although we clearly demonstrate tolerance at the T lymphocyte level, we cannot exclude at this time the additional possibility for B lymphocyte tolerance. This issue is currently being studied by using hapten-carrier tolerogens in an adoptive transfer model of tolerance we have developed (6) .
The mechanism by which T h 2 lymphocytes, or their precursors, become tolerant in vivo has yet to be determined. Possibilities include clonal deletion, anergy and cytokinemediated suppression (1) (2) 4, 6, 19, (41) (42) (43) (44) (45) . We have shown that a single feeding of antigen selectively induced anergy in T h 1 lymphocytes, and that in vitro treatment with IL-2 released the anergic cells for antigen-specific responses (6, 19) . This indicated that anergy could be achieved by exposing the immune system to antigen absorbed from the gut in the absence of co-stimulation (46) . Whether or not this is the case for T h 2 lymphocytes too remains to be investigated, but it is tempting to assume a general mechanism for induction of peripheral tolerance, particularly if both lymphocyte populations require different co-stimulatory signals (23, 47 
